News - Cytomos

Latest News

Cytomos Achieves ISO 9001 Certification with Zero Non-Conformances

12 August 2025
Cytomos is proud to announce that it has achieved ISO 9001:2015 certification with zero non-conformances identified during the external certification audit by BSI.
Click to read more

Cytomos secures £5million for Scale-Up

19 November 2024
Congratulations to the Cytomos team!
Click to read more

Improving on current challenges in cell analysis: Cytomos feature in Drug Discovery World, July 2024

05 July 2024
Insightful thought leadership article exploring current advances in technology that are helping improve cell analysis within drug discovery:
Click to read more

Advancing Cell Analytics: A Vision for the Future

01 April 2024
Cytomos was featured in Genetic Engineering & Biotechnology News insights: Advancing Cell Analytics: A Vision for the Future (genengnews.com). Read full article below.

Click to read more

Cytomos appoints new Chief Commercial and Innovation Officer and Techno-Commercial Adviser

23 January 2024
Driving the commercialisation strategy as the company evolves from an R&D to a product-based business, Cytomos is pleased to announce the appointment of Dr Fernanda Masri as Chief Commercial and Innovation Officer and Dr Christel Fenge as Techno-Commercial Adviser.
Click to read more

Cytomos December Press Coverage

21 December 2023
Cytomos has featured prominently in several trade and science journals this month, with articles on our AuraCyt™ cell analysis technology and our revamped website.
Click to read more

Cytomos selected to showcase AuraCyt™ cell analysis technology at BIA’s BioProcessUK Dragon’s Den session

23 October 2023
Cytomos’ CSO, Dr. Lindsay Fraser, will highlight the benefits and full potential of Cytomos’ transformative AuraCyt™ technology and take questions from inquisitive delegates.
Click to read more

Cytomos welcomes new Director as £4 million investment sets path for commercialisation of groundbreaking cell analysis technology

19 September 2023
Our appointment of industry leader Dr Sharon Brownlow as Non-Executive Director further enhances Cytomos’ senior management team and its unique value proposition to key industry markets.
Click to read more

Midlothian & East Lothian Business Awards Ceremony

10 April 2023
Thomas Clayton, Sevi Giakoumelou and Lindsay Fraser were delighted to attend the Midlothian & East Lothian Business Awards, organised by the Midlothian Chamber of Commerce.
Click to read more

Cytomos awarded £500k from Innovate UK

20 December 2022
Following the successful £1.6m investment round in autumn, we feel privileged to announce that Innovate UK has awarded Cytomos with £500k from the latest SMART grant funding round as part of the UK Government investment strategy in developing technologies to transform health and social care.
Click to read more

£1.6m additional funding secured

14 September 2022
This £1.6m funding – led by Archangels, alongside Scottish Enterprise and Old College Capital – will enable the development and qualification of Cytomos Dielectric Spectroscopy (CDS^TM) to move forward at pace and address the biopharma industry’s unmet needs.
Click to read more

Gordon Sharp joins the Cytomos senior team

05 September 2022
Gordon Sharp has joined the Executive team to lead our excellent Engineering team and continue working closely with the Scientific team.
Click to read more

Dr. Lindsay Fraser, joins the Cytomos senior team

02 September 2022
Lindsay joins the Executive team to lead our excellent Biology team and direct our scientific programme.
Click to read more